Lutz Heinemann
#126,196
Most Influential Person Now
Researcher
Lutz Heinemann's AcademicInfluence.com Rankings
Lutz Heinemanncomputer-science Degrees
Computer Science
#5313
World Rank
#5612
Historical Rank
Computational Linguistics
#710
World Rank
#722
Historical Rank
Machine Learning
#1362
World Rank
#1383
Historical Rank
Artificial Intelligence
#1597
World Rank
#1627
Historical Rank
Download Badge
Computer Science
Lutz Heinemann's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Lutz Heinemann Influential?
(Suggest an Edit or Addition)Lutz Heinemann's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) (1526)
- International Consensus on Use of Continuous Glucose Monitoring (2017) (1129)
- Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes. (2004) (613)
- Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. (2000) (460)
- Home Use of an Artificial Beta Cell in Type 1 Diabetes. (2015) (361)
- Smoking Is Associated With Progression of Diabetic Nephropathy (1994) (306)
- Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring (2018) (297)
- Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study (2006) (291)
- Sensors for glucose monitoring: technical and clinical aspects (2001) (270)
- Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial (2018) (253)
- Variability of insulin absorption and insulin action. (2002) (248)
- Comparison of the Numerical and Clinical Accuracy of Four Continuous Glucose Monitors (2008) (238)
- First human experiments with a novel non-invasive, non-optical continuous glucose monitoring system. (2003) (218)
- Definition, Classification and Diagnosis of Diabetes Mellitus. (2014) (218)
- Correlation between blood glucose concentration in diabetics and noninvasively measured tissue optical scattering coefficient. (1997) (184)
- Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report (2016) (176)
- Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin. (2005) (172)
- Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart. (1998) (162)
- Time‐action profile of the soluble, fatty acid acylated, long‐acting insulin analogue NN304 (1999) (158)
- Prevalence of renal artery stenosis in diabetes mellitus — an autopsy study (1991) (157)
- Prediction of the Risk to Develop Diabetes-Related Late Complications by Means of the Glucose Pentagon Model: Analysis of Data from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study (2012) (143)
- Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations (2017) (132)
- Non-invasive glucose monitoring in patients with diabetes: a novel system based on impedance spectroscopy. (2006) (132)
- Oral Insulin and Buccal Insulin: A Critical Reappraisal (2009) (128)
- Prandial Glycaemia After a Carbohydrate‐rich Meal in Type I Diabetic Patients: Using the Rapid Acting Insulin Analogue [Lys(B28), Pro(B29)] Human Insulin (1996) (126)
- Technosphere/Insulin--proof of concept study with a new insulin formulation for pulmonary delivery. (2002) (125)
- Day and Night Home Closed-Loop Insulin Delivery in Adults With Type 1 Diabetes: Three-Center Randomized Crossover Study (2014) (124)
- Insulin Injection Into Lipohypertrophic Tissue: Blunted and More Variable Insulin Absorption and Action and Impaired Postprandial Glucose Control (2016) (124)
- Time–action Profile of Inhaled Insulin (1997) (122)
- Insulin Aspart in a 30/70 Premixed Formulation: Pharmacodynamic properties of a rapid-acting insulin analog in stable mixture (1997) (120)
- Alternative routes of administration as an approach to improve insulin therapy: update on dermal, oral, nasal and pulmonary insulin delivery. (2001) (119)
- Insulin Infusion Set: The Achilles Heel of Continuous Subcutaneous Insulin Infusion (2012) (117)
- Time-Action Profiles of Novel Premixed Preparations of Insulin Lispro and NPL Insulin (1998) (111)
- CGM Versus FGM; or, Continuous Glucose Monitoring Is Not Flash Glucose Monitoring (2015) (109)
- Effect of insulin concentration, subcutaneous fat thickness and skin temperature on subcutaneous insulin absorption in healthy subjects (1994) (105)
- Non-invasive glucose monitoring in patients with Type 1 diabetes: a Multisensor system combining sensors for dielectric and optical characterisation of skin. (2009) (102)
- Non-invasive continuous glucose monitoring in Type I diabetic patients with optical glucose sensors (1998) (100)
- Finger Pricking and Pain: A Never Ending Story (2008) (100)
- The Failure of Exubera: Are We Beating a Dead Horse? (2008) (99)
- Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group (2015) (97)
- Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group (2019) (96)
- Severe Hypoglycemia Incidence and Predisposing Factors in 85 Pregnancies of Type I Diabetic Women (1992) (95)
- Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group (2019) (94)
- Consensus Report: The Current Role of Self-Monitoring of Blood Glucose in Non-Insulin-Treated Type 2 Diabetes (2011) (93)
- Action Profile of the Rapid Acting Insulin Analogue: Human Insulin B28Asp (1993) (93)
- Insulin glulisine: a faster onset of action compared with insulin lispro (2007) (91)
- Impact of diabetic nephropathy on pharmacodynamic and Pharmacokinetic properties of insulin in type 1 diabetic patients. (2001) (91)
- Day and Night Closed-Loop Control in Adults With Type 1 Diabetes (2013) (90)
- Injection-meal interval: recommendations of diabetologists and how patients handle it. (1999) (90)
- Real-Time Improvement of Continuous Glucose Monitoring Accuracy (2013) (88)
- Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer. (2000) (86)
- Ultrafast-Acting Insulins: State of the Art (2012) (86)
- Insulin Pump Risks and Benefits: A Clinical Appraisal of Pump Safety Standards, Adverse Event Reporting, and Research Needs (2015) (82)
- Closing the Loop in Adults, Children and Adolescents With Suboptimally Controlled Type 1 Diabetes Under Free Living Conditions: A Psychosocial Substudy (2017) (78)
- The Action Profiles of Human NPH Insulin Preparations (1989) (77)
- Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lispro. (2005) (77)
- Continuous Glucose Monitoring: Evidence and Consensus Statement for Clinical Use (2013) (76)
- A novel insulin formulation with a more rapid onset of action (2008) (76)
- Time‐action Profile of the Insulin Analogue B28Asp (1996) (76)
- Clinical Pharmacology of Human Insulin (1993) (76)
- Significance and Reliability of MARD for the Accuracy of CGM Systems (2017) (73)
- Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection. (2011) (72)
- No evidence for accumulation of insulin glargine (LANTUS®): a multiple injection study in patients with Type 1 diabetes (2002) (71)
- Further Evidence of Severe Allergic Contact Dermatitis From Isobornyl Acrylate While Using a Continuous Glucose Monitoring System (2018) (71)
- Accuracy and reliability of continuous glucose monitoring systems: a head-to-head comparison. (2013) (71)
- Time Delay of CGM Sensors (2015) (68)
- Subcutaneous continuous glucose monitoring: feasibility of a new microdialysis-based glucose sensor system. (2001) (68)
- Insulin resistance and the effect of insulin on blood pressure in essential hypertension. (1998) (68)
- Continuous glucose monitoring with glucose sensors: calibration and assessment criteria. (2003) (67)
- Absorption and metabolic effect of inhaled insulin: intrapatient variability after inhalation via the Aerodose insulin inhaler in patients with type 2 diabetes. (2002) (66)
- Improving the clinical value and utility of CGM systems: issues and recommendations (2017) (65)
- Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes. (2011) (63)
- Interferences and Limitations in Blood Glucose Self-Testing (2016) (63)
- Continuous glucose monitoring by means of the microdialysis technique: underlying fundamental aspects. (2003) (61)
- Oral glucose tolerance test and HbA1c for diagnosis of diabetes in patients undergoing coronary angiography the Silent Diabetes Study (2011) (60)
- Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women. (1999) (59)
- Adhesives Used for Diabetes Medical Devices (2016) (59)
- Measurement of insulin absorption and insulin action. (2004) (58)
- Glucose sensors and the alternate site testing-like phenomenon: relationship between rapid blood glucose changes and glucose sensor signals. (2003) (58)
- Definition, classification and diagnostics of diabetes mellitus (2018) (58)
- Quality of glucose measurement with blood glucose meters at the point-of-care: relevance of interfering factors. (2010) (57)
- Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes (2010) (56)
- New ways of insulin delivery. (2011) (56)
- Inhaled Technosphere® Insulin in Comparison to Subcutaneous Regular Human Insulin: Time Action Profile and Variability in Subjects with Type 2 Diabetes (2008) (55)
- Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline (2020) (55)
- Confusion Regarding Duration of Insulin Action (2014) (54)
- Continuous glucose monitoring: quality of hypoglycaemia detection (2013) (54)
- Rapid and long-acting analogues as an approach to improve insulin therapy: an evidence-based medicine assessment. (2001) (53)
- Hypoglycemic Symptoms and Frequency of Severe Hypoglycemia in Patients Treated With Human and Animal Insulin Preparations (1991) (52)
- Changes in Basal Insulin Infusion Rates With Subcutaneous Insulin Infusion (2009) (50)
- Reimbursement for Continuous Glucose Monitoring: A European View (2012) (49)
- Review: Current status of the development of inhaled insulin (2004) (49)
- Insulin Absorption from Lipodystrophic Areas: A (Neglected) Source of Trouble for Insulin Therapy? (2010) (48)
- Discrepancies Between Blood Glucose and Interstitial Glucose—Technological Artifacts or Physiology: Implications for Selection of the Appropriate Therapeutic Target (2017) (47)
- The Digital/Virtual Diabetes Clinic - the Future is Now. Recommendations from an International Panel on Diabetes Digital Technologies Introduction. (2020) (46)
- Effects of smoking on blood pressure and proteinuria in patients with diabetic nephropathy (1996) (44)
- Analytical Performance Requirements for Systems for Self-Monitoring of Blood Glucose With Focus on System Accuracy (2015) (44)
- Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled Insulin (2017) (44)
- Do Insulin‐treated Diabetic Patients Use an Injection‐meal‐interval in Daily Life? (1995) (44)
- Glucose clamps with the Biostator: a critical reappraisal. (1994) (43)
- How to Assess the Quality of Glucose Clamps? Evaluation of Clamps Performed With ClampArt, a Novel Automated Clamp Device (2015) (43)
- Performance of Blood Glucose Meters in the Low-Glucose Range: Current Evaluations Indicate That It Is Not Sufficient From a Clinical Point of View (2015) (43)
- Benefits and Limitations of MARD as a Performance Parameter for Continuous Glucose Monitoring in the Interstitial Space (2020) (41)
- Integrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: Results of the PDM-ProValue study program. (2018) (41)
- Is Self-Monitoring of Blood Glucose Appropriate for All Type 2 Diabetic Patients? The Fremantle Diabetes Study (2007) (40)
- Insulin Pump Therapy: What is the Evidence for Using Different Types of Boluses for Coverage of Prandial Insulin Requirements? (2009) (39)
- Reduced postprandial glycaemic excursion with biphasic insulin Aspart 30 injected immediately before a meal (2004) (39)
- Dose–response relationship of insulin glulisine in subjects with type 1 diabetes (2009) (39)
- Time‐action profile of insulin detemir and NPH insulin in patients with type 2 diabetes from different ethnic groups * (2006) (38)
- Hypoglycemia and insulin analogues: is there a reduction in the incidence? (1999) (37)
- Biphasic Insulin Aspart 30/70: Pharmacokinetics and Pharmacodynamics Compared With Once-Daily Biphasic Human Insulin and Basal-Bolus Therapy (2009) (37)
- Intra-Individual Variability of the Metabolic Effect of a Novel Rapid-Acting Insulin (VIAject™) in Comparison to Regular Human Insulin (2008) (37)
- Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects (1998) (37)
- AIR Inhaled Insulin in Subjects With Chronic Obstructive Pulmonary Disease (2007) (36)
- Biosimilar Insulins: How Similar is Similar? (2011) (36)
- HbA1c and Age in Non-Diabetic Subjects: An Ignored Association? (2016) (36)
- AP@home: A Novel European Approach to Bring the Artificial Pancreas Home (2011) (36)
- SPECTRUM: A Training and Treatment Program for Continuous Glucose Monitoring for All Age Groups (2017) (35)
- Overcoming obstacles: new management options. (2004) (35)
- Insulin Storage: A Critical Reappraisal (2020) (34)
- Reimbursement for Continuous Glucose Monitoring. (2016) (34)
- Day and Night Closed-Loop Control in AdultsWith Type 1 Diabetes A comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management (2013) (34)
- Comparison of Methods for Determination of Microalbuminuria in Diabetic Patients (1989) (34)
- U‐100, pH‐Neutral formulation of VIAject®: faster onset of action than insulin lispro in patients with type 1 diabetes (2012) (34)
- Noninvasive glucose measurement by monitoring of scattering coefficient during oral glucose tolerance tests. Non-Invasive Task Force. (2000) (34)
- Continuous Glucose Monitoring during Exercise in Patients with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion (2010) (34)
- Oral Insulin Reloaded (2014) (34)
- Biosimilar insulins: a European perspective (2014) (33)
- Open Source Closed-Loop Insulin Delivery Systems: A Clash of Cultures or Merging of Diverse Approaches? (2018) (33)
- Timing between the subcutaneous administration of insulin and consumption of a carbohydrate rich meal. (1992) (33)
- The blood glucose lowering effects of exercise and glibenclamide in patients with Type 2 diabetes mellitus (1998) (33)
- Four week administration of an ACE inhibitor and a cardioselective β‐blocker in healthy volunteers: no influence on insulin sensitivity (1995) (33)
- Current Trends in Continuous Glucose Monitoring (2014) (33)
- Continuous glucose monitoring: reliable measurements for up to 4 days with the SCGM1 system. (2003) (32)
- Hyperinsulinaemia is not linked with blood pressure elevation in patients with insulinoma (1992) (32)
- The "glucose pentagon": assessing glycemic control of patients with diabetes mellitus by a model integrating different parameters from glucose profiles. (2009) (32)
- An Overview of Current Regulatory Requirements for Approval of Biosimilar Insulins (2015) (31)
- Quality of HbA1c Measurement in the Practice (2015) (31)
- Limits to the Evaluation of the Accuracy of Continuous Glucose Monitoring Systems by Clinical Trials (2018) (31)
- Psychosocial Aspects of Continuous Glucose Monitoring (2016) (31)
- Evaluation of Isobornyl Acrylate Content in Medical Devices for Diabetes Treatment. (2019) (30)
- Euglycemic ketosis in patients with type 2 diabetes on SGLT2-inhibitor therapy—an emerging problem and solutions offered by diabetes technology (2017) (29)
- Inhaled micronized crystalline human insulin using a dry powder inhaler: dose‐response and time‐action profiles 1 (2004) (29)
- PHARMACOKINETICS AND GLUCODYNAMICS OF INSULIN LISPRO (1998) (28)
- Alternative delivery routes: inhaled insulin. (2002) (28)
- Biosimilar insulins: guidance for data interpretation by clinicians and users (2015) (28)
- Impact of CGM on the Management of Hypoglycemia Problems: Overview and Secondary Analysis of the HypoDE Study (2019) (27)
- Premixed formulations of insulin lispro. Activity profiles in type 1 diabetic patients. (1999) (27)
- Pharmacokinetics and pharmacodynamics of subcutaneously administered U40 and U100 formulations of regular human insulin. (1992) (27)
- Insulin Concentration in Vials Randomly Purchased in Pharmacies in the United States: Considerable Loss in the Cold Supply Chain (2018) (27)
- Reduction of Postprandial Glycemic Excursions in Patients with Type 1 Diabetes: A Novel Human Insulin Formulation versus a Rapid-Acting Insulin Analog and Regular Human Insulin (2011) (27)
- Effect of the urotensin-II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with Type 2 diabetes mellitus. (2009) (26)
- Estimation of Hemoglobin A1c from Continuous Glucose Monitoring Data in Individuals with Type 1 Diabetes: Is Time in Range All We Need? (2020) (26)
- Electrocardiographic changes during insulin-induced hypoglycemia in healthy subjects. (1998) (26)
- Continuous Glucose Monitoring Accuracy Results Vary between Assessment at Home and Assessment at the Clinical Research Center (2012) (26)
- Biosimilar insulins (2012) (25)
- Renal glucose excretion and tubular reabsorption rate related to blood glucose in subjects with type 2 diabetes with a critical reappraisal of the "renal glucose threshold" model. (2009) (25)
- Residual Beta Cell Function in Newly Diagnosed Type 1 Diabetes after Treatment with Atorvastatin: The Randomized DIATOR Trial (2011) (25)
- Dynamics of blood electrolytes in repeated hyper- and/or hypoglycaemic events in patients with type 1 diabetes (2011) (25)
- Skin Autofluorescence - A Non-invasive Measurement for Assessing Cardiovascular Risk and Risk of Diabetes. (2014) (25)
- Accuracy in Blood Glucose Measurement: What Will a Tightening of Requirements Yield? (2012) (25)
- Rethinking the Viability and Utility of Inhaled Insulin in Clinical Practice (2018) (25)
- Insulin Assay Standardization: Leading to Measures of Insulin Sensitivity and Secretion for Practical Clinical Care (2010) (24)
- Digital Diabetes Management: A Literature Review of Smart Insulin Pens (2021) (24)
- Are presently available insulin analogues clinically beneficial? (1997) (24)
- Comparison of the time-action profiles of U40- and U100-regular human insulin and the rapid-acting insulin analogue B28 Asp. (2009) (24)
- Insulin Pump and CGM Usage in the United States and Germany (2015) (24)
- PROMAXX® inhaled insulin: safe and efficacious administration with a commercially available dry powder inhaler (2009) (23)
- Performance Comparison of CGM Systems (2015) (23)
- Improved Preservation of Residual Beta Cell Function by Atorvastatin in Patients with Recent Onset Type 1 Diabetes and High CRP Levels (DIATOR Trial) (2012) (23)
- System accuracy of blood glucose monitoring systems: impact of use by patients and ambient conditions. (2013) (23)
- Atrial natriuretic factor in various stages of diabetic nephropathy. (1988) (23)
- Definition, Klassifikation und Diagnostik des Diabetes mellitus: Update 2020 (2020) (23)
- Effect of pramlintide on symptom, catecholamine, and glucagon responses to hypoglycemia in healthy subjects. (2004) (23)
- Continuous Glucose Monitoring (CGM) or Blood Glucose Monitoring (BGM): Interactions and Implications (2018) (22)
- The implanted glucose monitoring system Eversense: An alternative for diabetes patients with isobornyl acrylate allergy (2020) (21)
- Fluctuation and reproducibility of exposure and effect of insulin glargine in healthy subjects * (2008) (21)
- No Increase in the Duration of Action with Rising Doses of Insulin Aspart (2003) (21)
- Glucose monitoring by microdialysis: performance in a multicentre study (2009) (21)
- Simulated postaggression metabolism in healthy subjects: metabolic changes and insulin resistance. (1998) (21)
- Biosimilar Insulin and Costs (2016) (20)
- Bolus Advisors: Sources of Error, Targets for Improvement (2018) (20)
- Products for Monitoring Glucose Levels in the Human Body With Noninvasive Optical, Noninvasive Fluid Sampling, or Minimally Invasive Technologies (2021) (20)
- Hypoglycemia warning signal and glucose sensors: requirements and concepts. (2003) (20)
- Short‐term metabolic effects of prednisone administration in healthy subjects (2011) (20)
- Patch Pumps: Are They All the Same? (2018) (20)
- Continuous Subcutaneous Glucose Monitoring Shows a Close Correlation between Mean Glucose and Time Spent in Hyperglycemia and Hemoglobin A1c (2007) (20)
- Insulin Pump Occlusions: For Patients Who Have Been Around the (Infusion) Block (2017) (19)
- Noninvasive Continuous Monitoring of Vital Signs With Wearables: Fit for Medical Use? (2020) (19)
- Correlation between anthropometric parameters and abdominal fat volumes assessed by a magnetic resonance imaging method in patients with diabetes. (2004) (19)
- A rapid and reliable semiautomated method for measurement of total abdominal fat volumes using magnetic resonance imaging. (2003) (19)
- Time-action profile of the long-acting insulin analogue insulin glargine in comparison to NPH insulin in Japanese volunteers. (2003) (19)
- New ways of insulin delivery (2010) (18)
- Assessing the Analytical Performance of Systems for Self-Monitoring of Blood Glucose: Concepts of Performance Evaluation and Definition of Metrological Key Terms (2013) (18)
- Concentrated insulins: History and critical reappraisal (2018) (18)
- Insulin Infusion Sets: A Critical Reappraisal. (2016) (18)
- Insulin aspart. Commentaries (1999) (18)
- Evaluation of the SPECTRUM training programme for real‐time continuous glucose monitoring: A real‐world multicentre prospective study in 120 adults with type 1 diabetes (2020) (17)
- A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings. (2022) (17)
- Basal—Prandial Insulin Delivery in Type 2 Diabetes Mellitus via the V-Go™: A Novel Continuous Subcutaneous Infusion Device (2008) (17)
- Action profiles of fast onset insulin analogues (1990) (17)
- Clinical Application and Challenges of Blood Glucose Measurement Technology for Self-Monitoring (2008) (17)
- New ways of insulin delivery (2012) (17)
- HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Daily Injections. (2015) (17)
- Biosimilar Insulins (2014) (17)
- Impact of particle size and aerosolization time on the metabolic effect of an inhaled insulin aerosol. (2004) (17)
- Patch pump versus conventional pump: postprandial glycemic excursions and the influence of wear time. (2013) (17)
- Measurement Uncertainty Impacts Diagnosis of Diabetes Mellitus: Reliable Minimal Difference of Plasma Glucose Results (2019) (16)
- Usability of Medical Devices for Patients With Diabetes Who Are Visually Impaired or Blind (2016) (16)
- The Diabetes Technology Society Green Diabetes Initiative (2020) (16)
- Continuous Glucose Monitoring in People With Type 1 Diabetes on Multiple-Dose Injection Therapy: The Relationship Between Glycemic Control and Hypoglycemia (2019) (16)
- Insulin sensitivity in patients with essential hypertension: no influence of the ACE inhibitor enalapril. (1999) (16)
- Insulin aspart has a shorter duration of action than human insulin over a wide dose‐range (2013) (16)
- Freestyle libre 2: The new isobornyl acrylate free generation (2020) (16)
- Evaluating Glucose Control With a Novel Composite Continuous Glucose Monitoring Index (2020) (16)
- Modeling of Diabetes and Its Clinical Impact (2018) (16)
- Inhaled insulin as adjunctive therapy in subjects with type 2 diabetes failing oral agents: a controlled proof‐of‐concept study (2006) (16)
- A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment (2014) (15)
- Short-term evaluation of an electro-chemical system (ExacTech) for blood glucose monitoring. (1990) (15)
- Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice (2022) (15)
- Continuous glucose monitoring: an overview of today's technologies and their clinical applications. (2002) (15)
- Evidence for continuous glucose monitoring: sufficient for reimbursement? (2014) (15)
- Usage of Hydrocolloid-Based Plasters in Patients Who Have Developed Allergic Contact Dermatitis to Isobornyl Acrylate While Using Continuous Glucose Monitoring Systems (2020) (15)
- Interrelations between Diabetes Therapy, Self-Monitoring of Blood Glucose, Blood Glucose and Non-fatal or Fatal Endpoints in Patients with Type 2 Diabetes (2007) (14)
- Journal of Diabetes Science and Technology: Evolution of an Electronic Journal (2012) (14)
- Continuous Glucose Monitoring and Clinical Trials (2009) (14)
- Definition, Klassifikation und Diagnostik des Diabetes mellitus: Update 2021 (2020) (14)
- Myocardial infarction and stroke in early years after diagnosis of type 2 diabetes: risk factors and relation to self-monitoring of blood glucose. (2009) (14)
- Quantification of total abdominal fat volumes using magnetic resonance imaging. (2002) (14)
- Fitting nonlinear regression models with correlated errors to individual pharmacodynamic data using SAS software (1995) (14)
- Integrated Personalized Diabetes Management (PDM) (2016) (14)
- Insulin pens and new ways of insulin delivery. (2013) (13)
- IQWiG Reanalyzes and Raises Questions About an Article by Ly et al Which Concluded Low Glucose Suspend Is Very Beneficial (2016) (13)
- Self-measurement of Blood Glucose and Continuous Glucose Monitoring – Is There Only One Future? (2018) (13)
- Self-measurement of Blood Glucose and Continuous Glucose Monitoring – Is There Only One Future? (2018) (13)
- Enhancement of blood glucose lowering effect of a sulfonylurea when coadministered with an ACE inhibitor: results of a glucose‐clamp study (2005) (13)
- Toward Development of Psychosocial Measures for Automated Insulin Delivery (2016) (13)
- Comparative dose-related time-action profiles of glibenclamide and a new non-sulphonylurea drug, AG-EE 623 ZW, during euglycaemic clamp in healthy subjects (1994) (13)
- Assessing the effectiveness of 3 months day and night home closed-loop insulin delivery in adults with suboptimally controlled type 1 diabetes: a randomised crossover study protocol (2014) (13)
- We Need More Research and Better Designs for Insulin Infusion Sets (2014) (13)
- Nonlinear Metabolic Effect of Insulin Across the Blood Glucose Range in Patients with Type 1 Diabetes Mellitus (2010) (12)
- The Systemic Immune Network in Recent Onset Type 1 Diabetes: Central Role of Interleukin-1 Receptor Antagonist (DIATOR Trial) (2013) (12)
- Metformin and Exercise: no Additive Effect on Blood Lactate Levels in Healthy Volunteers (1997) (12)
- Artificial Pancreas Systems for People With Type 2 Diabetes: Conception and Design of the European CLOSE Project (2018) (12)
- Storage Conditions of Insulin in Domestic Refrigerators and When Carried by Patients: Often Outside Recommended Temperature Range. (2019) (12)
- Blood Glucose Monitoring Data Should Be Reported in Detail When Studies About Efficacy of Continuous Glucose Monitoring Systems Are Published (2018) (12)
- Insulin Pump Therapy for Patients With Type 2 Diabetes Mellitus: Evidence, Current Barriers, and New Technologies (2020) (12)
- Benefit of Digital Tools Used for Integrated Personalized Diabetes Management: Results From the PDM-ProValue Study Program (2019) (12)
- Near-normotension and near-normoglycemia in blind type I diabetic patients with overt diabetic nephropathy. (1990) (12)
- What Are the Next Steps in Continuous Glucose Monitoring? (2014) (12)
- Help! Someone Is Beeping . . . (2014) (11)
- Variability of Insulin Action: Does It Matter? (2008) (11)
- “Do It Yourself” (DIY)—Automated Insulin Delivery (AID) Systems: Current Status From a German Point of View (2019) (11)
- [Pitfalls in the Diagnosis of Diabetes: Are we too Lax with Laboratory Parameters?] (2018) (11)
- The Effects and Effect Sizes of Real-Time Continuous Glucose Monitoring on Patient-Reported Outcomes: A Secondary Analysis of the HypoDE Study. (2019) (11)
- Open source automated insulin delivery: addressing the challenge (2019) (11)
- Considerations for an Institution for Evaluation of Diabetes Technology Devices to Improve Their Quality in the European Union (2013) (11)
- 35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
- Impact of Biosimilar Insulins on Clinical Practice (2014) (11)
- Diabetes Technology and Waste: A Complex Problem Piling Up! (2019) (11)
- Practical Recommendations for Glucose Measurement, Glucose Monitoring and Glucose Control in Patients with Type 1 or Type 2 Diabetes in Germany. (2018) (11)
- Optimizing insulin pump therapy: the potential advantages of using a structured diabetes management program (2015) (10)
- Beneficial effects of external muscle stimulation on glycaemic control in patients with type 2 diabetes. (2008) (10)
- PsychDT Working Group (2015) (10)
- Higher HbA1c Measurement Quality Standards are Needed for Follow-Up and Diagnosis: Experience and Analyses from Germany (2018) (10)
- Determination of Postprandial Glycemic Responses by Continuous Glucose Monitoring in a Real-World Setting (2019) (10)
- Quality Control of Insulins and Biosimilar Insulins (2016) (10)
- Advances in Insulin Pump Infusion Sets Symposium Report (2021) (10)
- New Insulins, Biosimilars, and Insulin Therapy. (2018) (10)
- Parameters Affecting Postprandial Blood Glucose: Effects of Blood Glucose Measurement Errors (2008) (10)
- A cross‐over evaluation of different methods and devices to measure blood pressure in type 1 diabetic patients with nephropathy (2000) (10)
- Patient-Reported Outcomes and Continuous Glucose Monitoring: Can We Do Better With Artificial Pancreas Devices? (2015) (10)
- AIR insulin capsules of different dose strengths may be combined to yield equivalent pharmacokinetics and glucodynamics. (2009) (10)
- Boluses in Insulin Therapy (2017) (9)
- Measuring Glucose Concentrations: Daily Practice, Current and Future Developments (2008) (9)
- Altered Disease Course after Initiation of Self-Monitoring of Blood Glucose in Noninsulin-Treated Type 2 Diabetes (ROSSO 3) (2007) (9)
- Intermittent Use of Continuous Glucose Monitoring: Expanding the Clinical Value of CGM (2020) (9)
- Comment on "The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System" by Bailey et al. (2016) (9)
- Intrauterine Devices Are Safe and Effective Contraceptives for Type I Diabetic Women: Further evidence (1995) (9)
- Administration of Biosimilar Insulin Analogs: Role of Devices. (2017) (9)
- Subcutaneous Insulin Administration: Sufficient Progress or Ongoing Need? (2018) (9)
- AIR BUBBLES IN INSULIN PENS (1989) (8)
- Options for the Development of Noninvasive Glucose Monitoring (2016) (8)
- The pharmacokinetic and pharmacodynamic properties of biphasic insulin Aspart 70 (BIAsp 70) are significantly different from those of biphasic insulin Aspart 30 (BIAsp 30). (2005) (8)
- [Action profile of human ultralente insulin compared with human NPH-insulin]. (2008) (8)
- Critical Reappraisal of the Time-in-Range: Alternative or Useful Addition to Glycated Hemoglobin? (2020) (8)
- Type 2 Diabetes Phenotype and Progression is Significantly Different if Diagnosed before versus after 65 Years of Age (2008) (8)
- Bolus Calculator Safety Mandates a Need for Standards (2017) (8)
- Subcutaneous Injection versus Subcutaneous Infusion of Insulin: Are the Rates of Absorption Truly the Same? (2011) (8)
- Lipohypertrophy and the Artificial Pancreas (2014) (7)
- Biosimilar Insulin and Insulin Antibodies (2013) (7)
- Will Biosimilar Insulins Be Cheaper? (2017) (7)
- Self monitoring of blood glucose in blind diabetic patients (1997) (7)
- Effect of C-peptide on glucose metabolism in patients with type 1 diabetes. (2002) (7)
- Time-action profiles of the intermediate-acting insulin analogue des(64,65)-human proinsulin. (1995) (7)
- If PBMs Guard Access to Drugs, Then Quis Custodiet Ipsos Custodies? (Who Will Guard the Guardians?) (2016) (7)
- Assessing Rates of Hypoglycemia as an End Point in Clinical Trials (2015) (7)
- Control Solutions for Blood Glucose Meters (2015) (7)
- How Well Do Patients With Type 1 Diabetes Measure Their Blood Glucose in Daily Life? (1998) (7)
- Self-Monitoring of Blood Glucose in Noninsulin-Treated Patients with Type 2 Diabetes: A Never Ending Story? (2007) (7)
- Reliable Detection of Atrial Fibrillation with a Medical Wearable during Inpatient Conditions (2020) (7)
- Open source automated insulin delivery: addressing the challenge. (2019) (7)
- An Opportunity to Increase the Benefit of CGM Usage: The Need to Train the Patients Adequately (2019) (7)
- Response to Ward (2002) (7)
- Future of Diabetes Technology (2017) (7)
- Glucose Measurement and Control in Patients with Type 1 or Type 2 Diabetes. (2019) (6)
- Blood Glucose Meter Market: This World is Undergoing Drastic Changes (2013) (6)
- Clinical development of continuous glucose monitoring systems: considerations for the optimal strategy (2006) (6)
- [Clinical effects and pharmacodynamics of insulin analogs lispro, aspart and glargin]. (2001) (6)
- The Diabetes Technology Society Green Declaration (2021) (6)
- Noninvasive Glucose Monitoring Systems: Will We Ever Have Such Sensors for Practical Use? (2007) (6)
- The YSI 2300 Analyzer Replacement Meeting Report (2020) (6)
- Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development (2015) (6)
- Are All Clinical Studies Sponsored by Industry Not Valid? (2008) (6)
- Green Diabetes Summit 2021 (2021) (6)
- Measurement of insulin sensitivity: influence of potassium supply during euglycaemic glucose clamps in healthy volunteers. (2009) (6)
- Reviewer: an endangered species?! (2015) (6)
- Device Connectivity (2015) (6)
- Role of Physicians in the Pharmaceutical Industry and Clinical Research Organizations: Take More Pride in Your Work (2008) (6)
- Replacement of Blood Glucose Measurements by Measurements With Systems for Real-Time Continuous Glucose Monitoring (rtCGM) or CGM With Intermittent Scanning (iscCGM): A German View (2017) (6)
- New Insulins, Biosimilars, and Insulin Therapy. (2019) (6)
- Glycemic exposure is affected favorably by inhaled human insulin (Exubera) as compared with subcutaneous insulin glargine (Lantus) in patients with type 2 diabetes. (2009) (6)
- Accuracy of blood glucose self monitoring in elderly insulin treated diabetic patients. (1991) (6)
- Inhaled Insulin: Dead Horse or Rising Phoenix? (2018) (5)
- HbA1c—Glycated Hemoglobin and Diabetes Mellitus: A Book Review (2010) (5)
- Dependency of the metabolic effect of sc-injected human regular insulin on intra-abdominal fat in patients with type 2 diabetes. (2004) (5)
- Measurement Quality of Blood Glucose Meters: Is There a Need for an Institution with an Unbiased View? (2007) (5)
- DiaDigital@@@DiaDigital: Unterstützung von Patienten und Diabetologen bei der Nutzung von Apps@@@Support for patients and diabetologists by the use of apps (2016) (5)
- Enalapril and metoprolol in diabetic nephropathy. (1990) (5)
- Response to Comment on Bergenstal et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018;41:2275–2280 (2018) (5)
- DiaDigital Apps: Evaluation of Smartphone Apps Using a Quality Rating Methodology for Use by Patients and Diabetologists in Germany (2018) (5)
- Definition, Klassifikation und Diagnostik des Diabetes mellitus (2019) (5)
- Are Type 2 Diabetes Patients Who Self-Monitor Blood Glucose Special? The Role of Confounders in the Observational ROSSO Study (2009) (5)
- [Risk factors in hyperlipidemic patients with coronary heart disease one year after PTCA]. (1994) (5)
- Future directions for insulin therapy and diabetes treatment. (2007) (5)
- More Green, Less Red: How Color Standardization May Facilitate Effective Use of CGM Data (2021) (5)
- „Do it yourself“ (DIY) Automated Insulin Delivery (AID) Systems: Stand der Dinge (2019) (5)
- Pulsatile insulin infusion and glucose‐homeostasis in well‐controlled Type 1 (insulin‐dependent) diabetic patients (1989) (5)
- Self-Monitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus (2022) (5)
- AP@home (2016) (5)
- Biosimilar insulins: how will this story evolve? (2012) (5)
- Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy. (1996) (4)
- Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association (2022) (4)
- Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association. (2022) (4)
- Algorithms for Automated Insulin Delivery: An Overview (2021) (4)
- Further Development of Artificial Pancreas: Blocked by Patents? (2008) (4)
- Glucose Measurement by Affinity Sensor and Pulsed Measurements of Fluidic Resistances (2014) (4)
- External Physical and Technical Influences on Medical Devices for Diabetes Therapy (2022) (4)
- Impact of symptomatic upper respiratory tract infections on insulin absorption and action of Technosphere inhaled insulin (2016) (4)
- A Comprehensive Performance Evaluation of Five Blood Glucose Systems in the Hypo-, Eu-, and Hyperglycemic Range (2016) (4)
- No evidence for accumulation of HOE901 after multiple injections in type I diabetic patients (2000) (4)
- (Analytical) Accuracy of Blood Glucose Meters and Patients: How Do They Come Together? (2013) (4)
- Coverage of Prandial Insulin Requirements: An Elusive Goal. (2017) (4)
- Data Transfer From Biostator: Facilitation of Analysis of Glucose-Clamp Experiments (1992) (4)
- Inhaled Insulin: Take a Deep Breath, but How? (2008) (4)
- Diabetes management intervention studies: lessons learned from two studies (2021) (4)
- Integrated personalized diabetes management goes Europe: A multi-disciplinary approach to innovating type 2 diabetes care in Europe. (2020) (4)
- Glucose infusion rates during euglycaemic clamps do not precisely reflect action profiles of subcutaneously injected insulin (2004) (4)
- Hypoglycemia detection by ECG recording? (1995) (4)
- Level of Digitalization in Germany: Results of the Diabetes Digitalization and Technology (D.U.T) Report 2020 (2020) (4)
- First-phase insulin secretion has limited impact on postprandial glycemia in subjects with type 2 diabetes: correlations between hyperglycemic glucose clamp and meal test. (2010) (4)
- Therapy adjustments in people with type 1 diabetes with impaired hypoglycemia awareness on multiple daily injections using real-time continuous glucose monitoring: a mechanistic analysis of the HypoDE study (2021) (3)
- Improving the Patient Experience With Longer Wear Infusion Sets Symposium Report (2022) (3)
- Methods for Quantifying Insulin Sensitivity and Determining Insulin Time-Action Profiles (2015) (3)
- The Need for Sharps Waste Disposal Guidelines for Commercial Airports (2021) (3)
- Lipohypertrophic Skin Changes in Patients With Diabetes: Visualization by Infrared Images (2018) (3)
- Differences in Relative Bioavailability (BA) of Inhalation InsulinDetermined using Insulin and Glucose Levels Following Subcutaneous andInhalation Administration in Humans (2011) (3)
- Future of Diabetes-Technology: Certificate of Competency for Insulin Pumps and Continuous Glucose Monitors (2012) (3)
- Needle Technology for Insulin Administration: A Century of Innovation (2021) (3)
- Real-Time Continuous Glucose Monitoring Usage in Pilots with Diabetes: An Option to Improve Safety. (2018) (3)
- Interferences With CGM Systems: Practical Relevance? (2021) (3)
- Are all glucose solutions used for oGTT equal? (2022) (3)
- 1262-P: Physicians’ Perceptions and Attitudes towards Digitalization and New Technologies in Diabetes Care (2019) (2)
- Preulcerous Risk Situation in Diabetic Foot Syndrome: Proposal for a Simple Ulcer Prevention Score (2020) (2)
- Effect of 8 hours of hyperinsulinaemia on haemostatic parameters in healthy man (1989) (2)
- Diabetes Technology and Waste: A Complex Story (2021) (2)
- New Insulins, Biosimilars, and Insulin Therapy. (2016) (2)
- Ø[The effect of physical exercise on glycemia on healthy subjects following administration of glimepiride]. (1996) (2)
- Pharmacodynamic properties of Viaject™: A novel rapid-acting regular human insulin (2006) (2)
- 6. New Ways of Insulin Delivery (2012) (2)
- New Insulins, Biosimilars, and Insulin Therapy. (2016) (2)
- New Insulins, Biosimilars, and Insulin Therapy. (2021) (2)
- Elderly Patients With Diabetes: Special Aspects to Consider (2019) (2)
- Effect of 4-hour hyperglycaemia and hyperinsulinaemia on plasma atrial natriuretic factor concentrations. (1995) (2)
- [Atrial natriuretic factor in patients with type 1 diabetes mellitus in various stages of diabetic nephropathy]. (1988) (2)
- Diabetes-Technologie: Stand der Dinge (2012) (2)
- Reply to comment on: Martin S, Schneider B, Heinemann L et al (2006) Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 49:271–278 (2006) (2)
- The Diabetes Technologist: A Practical Solution in Dealing with Technology in Everyday Practice? (2012) (2)
- Comparative Handling Analysis of Different Insulin Pump Systems (2018) (2)
- New Insulins, Biosimilars, and Insulin Therapy. (2017) (2)
- Response to “Discrepancies Between Blood Glucose and Interstitial Glucose—Technological Artifacts or Physiology: A Reply” (2018) (2)
- [Interactive thresholded volumetry of abdominal fat using breath-hold t1-weighted magnetic resonance imaging]. (2006) (2)
- A Review of its Therapeutic Use as a Long-Acting Agent for the Management of Type 1 and 2 Diabetes Mellitus (2001) (2)
- Feasibility of Wearable-Based Remote Monitoring in Patients During Intensive Treatment for Aggressive Hematologic Malignancies (2022) (2)
- Air Bubbles in Insulin Pumps: A Clinically Relevant Issue? (2022) (1)
- Erratum to: Oral glucose tolerance test and HbA1c for diagnosis of diabetes in patients undergoing coronary angiography: the Silent Diabetes Study (2011) (1)
- Biotrans: Description of a Data Transfer Program for the Biostator (1993) (1)
- Insulin Analogues: A Critical View on Their Future (2008) (1)
- Lack of effects of the β3-adrenoreceptor agonist UL-TG 307 on insulin sensitivity and insulin secretion in Type 2 diabetic patients (2009) (1)
- Journal of Diabetes Science and Technology: A Success Story! (2020) (1)
- Continuous glucose monitoring: A training programme for all age groups (2017) (1)
- Freedom of Speech and Science: Can Companies Force Us to Withdraw Data They Don't Like? (2013) (1)
- Real-time CGM can predict severe hypoglycemia in people with type 1 diabetes: combined analysis of the HypoDE and DIAMOND trials. (2022) (1)
- Trust: Need for an Improved Communication between the Public World and the Pharmaceutical Companies (2009) (1)
- Diabetes Technology: Many Steps From an Idea to a Product (2022) (1)
- Insulin Titration Guidelines for Patients With Type 1 Diabetes: It Is About Time! (2022) (1)
- Insulin analogues--not faster than U 40 regular human insulin? (1993) (1)
- Future directions in insulin therapy and treatment of diabetes mellitus: a critical comment. (2007) (1)
- Input of Patients for New Diabetes Technology Products (2021) (1)
- PIH10 ESTIMATING THE BURDEN OF WOMEN SUFFERING FROM PMS/PMDD: ANALYSIS OF A CROSS-SECTIONAL DATASET (2009) (1)
- Pilots and Diabetes Technology (2017) (1)
- In Response to Letters to the Editor From the American Diabetes Association and Eli Lilly in Regard to: Insulin Concentration in Vials Randomly Purchased in Pharmacies in the United States: Considerable Loss in the Cold Supply Chain (2018) (1)
- Patch Pumps: Periodic Insulin Delivery Patterns. (2022) (1)
- Pathological Significance of Pathological Significance of Glycemic Variability Glycemic Variability (2011) (1)
- 857-P: Attitudes of Physicians to Chances, Risks, and Future Options Regarding Digitalization and New Technologies in Diabetes (2020) (1)
- Analysis of the Nova Stat Strip® Glucose Meter for Real-Time Blood Glucose Determinations during Glucose Clamp Studies: “Don't Swap Horses in Midstream” (2010) (1)
- Clinical Experience with a Tubing-Free Insulin Pump System (2009) (1)
- EASD Diabetes Technology Meeting (2014) (1)
- Erratum: Definition, Klassifikation und Diagnostik des Diabetes mellitus (2018) (1)
- A 4-h hyperglycaemic excursion induces rapid and slow changes in major electrolytes in blood in healthy human subjects (2012) (1)
- Diabetes Management Technology for Patients with Visual Impairment and Blindness (2015) (1)
- Comment on Umpierrez and Klonoff. Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes Care 2018;41:1579–1589 (2019) (1)
- Response to the Comment by K. Hood to “Do It Yourself” (DIY)—Automated Insulin Delivery (AID) Systems: Current Status From a German Point of View (2021) (1)
- Diagnostik des Gestationsdiabetes mellitus in der Praxis (2020) (1)
- What Do Healthcare Professionals and People With Diabetes Know About Insulin Transport and Storage? A Multinational Survey (2021) (1)
- Patch Pumps: What are the advantages for people with diabetes? (2022) (1)
- Alternate site (like) phenomenon: Rapid changes from hypoglycemic to hyperglycemic glucose levels in a clinical-experimental study in patients with type 1 diabetes (2006) (1)
- Correction: Higher HbA1c Measurement Quality Standards are Needed for Follow-Up and Diagnosis: Experience and Analyses from Germany (2018) (1)
- Insulin pens and new ways of insulin delivery. (2015) (0)
- Improvements in Patient Care by an Integrated Personalized Diabetes Management (iPDM) Approach May Be Driven by the Structured Process and How Physicians Use Data Sources (2018) (0)
- Reliable detection of atrial fibrillation with a medical wearable under inpatient conditions (CoMMoD-A-fib) (2020) (0)
- The Use of the Continuous The Use of the Continuous Glucose Monitors in Glucose Monitors in Pr Pr egnancy egnancy (2007) (0)
- Wearables for Non-Invasive Continuous Monitoring of Vital Signs: Fit for Medical Use? (2020) (0)
- 627-P: Comparison of Attitudes of Physcians, Parents, and People with Diabetes towards Digitalization and New Technologies in Diabetes (2022) (0)
- Lack of effects of the beta3-adrenoreceptor agonist UL-TG 307 on insulin sensitivity and insulin secretion in Type 2 diabetic patients. (1999) (0)
- 795-P: Significance and Future Trends of AID Systems from the Perspective of Physicians (2022) (0)
- Chronic intermittent intravenous insulin therapy: really a new therapeutic option? (2001) (0)
- 858-P: Different Attitudes of Physicians, Parents of Children with Diabetes, and People with Diabetes towards Digitization in Diabetes (2020) (0)
- 2179-PUB: Trends in the Use of Diabetes Technologies in Germany (2020) (0)
- 338-OR: Evaluation of the Spectrum Training Program for Real-Time Continuous Glucose Monitoring: A Multicenter Prospective Study in 120 Adults with Type 1 Diabetes (2020) (0)
- Subcutaneous glucose monitoring: Microdialysis vs. intracorporeal. Authors' replies (2002) (0)
- Excessive Glycaemic Variability Excessive Glycaemic Variability as an Indication for CSII as an Indication for CSII (2008) (0)
- Do more "artificial" Diagnoses of Gestational Diabetes come through the Use of nitrate containing Blood Collection Tubes? (2015) (0)
- Identifying people at risk for severe hypoglycemia by CGM in a sample of people with reduced hypoglycemia awareness (2017) (0)
- Is brittle diabetes an Is brittle diabetes an indication for alternative indication for alternative methods of insulin delivery? methods of insulin delivery? (2007) (0)
- PDB33 COST-EFFECTIVENESS OF THE PDM-PROVALUE STUDY PROGRAM IN INSULIN-TREATED PATIENTS WITH TYPE 2 DIABETES MELLITUS FROM THE GERMAN STATUTORY HEALTHCARE PERSPECTIVE (2019) (0)
- Chapter 9 The future of pumps and sensors: research and development (2009) (0)
- [Continuous monitoring of blood glucose by non-invasive methods]. (2000) (0)
- Impact of rtCGM Usage on a Combined Patient Reported Outcome—A Post-Hoc Analysis of the HypoDE Study (2018) (0)
- PS12 - 62. Continuous glucose monitoring accuracy assessed at home is seemingly better than when assessed at the clinical research centre (2011) (0)
- [Practical aspects in the use of biosimilar insulins]. (2016) (0)
- Free-living Home Use of an Artificial Beta Cell in Type 1 Diabetes (2015) (0)
- [Analytical Quality of Glucose Measurements in Germany]. (2022) (0)
- The Relationship between A1C and Hypoglycemia in the HypoDE Study (2018) (0)
- [Comparison of two insulin glargine formulations: biosimilar vs. reference product]. (2016) (0)
- [Do 3rd-generation ovulation inhibitors have a new risk profile?]. (1996) (0)
- New Insulins, Biosimilars, and Insulin Therapy. (2022) (0)
- Can CGM Discriminate Between Type 1 Diabetes Patients With and Without Severe Hypoglycaemia? Results of the Baseline Assessment from the HypoDE Study (2017) (0)
- [Google CGM: does this product already helps patients with diabetes?]. (2014) (0)
- DiaDigital, apps and digital health applications: Résumé after 5 years and afterwards? (2020) (0)
- Treating an Unconscious Patient With Diabetes Wearing a Device Attached to Their Body (2022) (0)
- Journal of Diabetes Science and Technology and the Diabetes Technology Community (2007) (0)
- Diabetes-Technology and the Environment: What Do We Have to Consider? (2022) (0)
- Understanding Biosimilar Insulins - Development, Manufacturing, and Clinical Trials. (2022) (0)
- Rapid Development of Technology in General and Diabetes Technology (2022) (0)
- The Effect of the Environment on Medical Devices (2023) (0)
- Definition, Klassifikation, Diagnostik und Differenzialdiagnostik des Diabetes mellitus: Update 2022 (2022) (0)
- Formation of Air Bubbles When (Re-) filling Insulin in the Pump (2022) (0)
- Reliable blood glucose measurement with the APEC glucose analyser (1997) (0)
- [Future diagnostic possibilities with continuous glucose monitoring and their indications in daily life]. (2008) (0)
- Cyclic Guanosine Monophosphate Concentrations in Type 1 Diabetic Patients in Different Stages of Diabetic Nephropathy (1989) (0)
- [Analytical Quality of Glucose Measurements in Germany]. (2022) (0)
- Diabetologists' and Patients' Views on Continuous Glucose Monitoring: Do They Talk about the Same Story? (2008) (0)
- New Insulins, Biosimilars, and Insulin Therapy. (2023) (0)
- Why sporadic glucose monitoring Why sporadic glucose monitoring when there is Continuous (CGM) (2014) (0)
- Lipohypertrophy and Insulin. An Old Dog that Needs New Tricks. (2023) (0)
- Self-monitoring of blood glucose in type 2 diabetes: Steps toward consensus [2] (2007) (0)
- Language Matters: Connected Pens, Smart Pens, Connected Smart Pens, or Just Digital Pens? (2023) (0)
- Beneficial effects of a hypertension and treatment programme in blind type I diabetic patients with overt nephropathy (1994) (0)
- Assessment of β-Cell Function (2015) (0)
- Need of the Disinfection of the Skin before the Capillary Blood Isolation for the Glucose Measurement in the Hospital from the Point of View of the diabetological Specialist Society (2016) (0)
- Expenditure for the Development of a Medical Device: Much Higher Than Commonly Assumed (2021) (0)
- People with Type 1 Diabetes and Increased Hypoglycemia Frequency have a Higher Risk for Nocturnal Hypoglycemia During the Second Half of the Night (2017) (0)
- Diabetes Education for Adults Diabetes Education for Adults with Diabetes (Part 2) with Diabetes (Part 2) (2013) (0)
- Continuous glucose monitoring before and after exercise in patients with type 1 diabetes on CSII (2007) (0)
- Bruising—An Ignored Issue? (2021) (0)
- Occurrence of severe hypoglycaemic events in the future: analysis of CGM data of the HypoDE study (2020) (0)
- The Relationship between A1C and Hypoglycemia in the Diamond Study (2018) (0)
- Expanding The Use Of Glucose Monitoring Technology To Enhance Diabetes Care (2018) (0)
- 1495-PUB: Insulin Patch Pumps: Are There Patient-Related Advantages for People with Diabetes? (2022) (0)
- Insulin Aspart (2012) (0)
- Diabetestechnologie@@@Diabetes technology (2014) (0)
- First European Diabetes Technology and Transplantation Meeting in Montpellier, February 4–6, 2007: Europe is Back! (2008) (0)
- rtCGM Usage Is Associated with a Significant Reduction of Time Spent in Hypoglycemia in Patients with Type 1 Diabetes Treated with Multiple Daily Injections—Results of the HypoDE Study (2018) (0)
- Subcutaneous glucose monitoring - Microdialysis vs. intracorporeal - Response (2002) (0)
- Are presently available insulin analogues clinically beneficial? : Insulin: action and secretion (1997) (0)
- Freedom of Science – Can Industry Influence What Scientists Publish? (2010) (0)
- Rapid communication Action profiles of fast onset insulin analogues (1990) (0)
- HypoDE: Research Design and Methods of an RCT Evaluating the Impact of Real-Time-CGM (2016) (0)
- Storage Conditions of Insulin in Domestic Refrigerators and Carried by Patients—Insulin Is Often Stored Outside Recommended Temperature Range (2018) (0)
- Predictors of Hypoglycemia Avoidance in a Randomized Controlled rtCGM Trial (HypoDE) (2018) (0)
- Accuracy and Reliability of Current Continuous Glucose Monitoring (CGM) systems; a Direct Comparison (2012) (0)
- 591-P: Green Diabetes: What Do People with Diabetes Think about Packaging Waste and Sustainability? (2022) (0)
- 281-OR: Directness and Sustainability of rtCGM Effects on Hypoglycemia: A Secondary Analysis of the Hypode Study (2019) (0)
- Patients’ Experience of New Technologies and Digitalization in Diabetes Care in Germany (2021) (0)
- [Analysis of the quality of health care for patients with type 2 diabetes enrolled in statutory or private health plans]. (2008) (0)
- The Role of Neuropathy in Diabetic Foot (2017) (0)
- Evidence and Diabetes Technology: A Catch-22? (2023) (0)
- Freedom of Science - Can Industry Influence What Scientists Publish? (2014) (0)
- Personal Considerations on Personal Considerations on Clinical Development of Clinical Development of Continuous Glucose Continuous Glucose Monitoring Systems Monitoring Systems (2007) (0)
- Subcutaneous continuous glucose monitoring reveals insight into long-term management of diabetes through a tight correlation of time spent in hyperglycemia vs. HbA1c. (2002) (0)
- Insulin pens and new ways of insulin delivery. (2014) (0)
- AGDT Opinion on the Replacement of Blood Glucose Measurements by Measurements with continuous Real-time Glucose Monitoring Systems (rtCGM) or CGM with intermittent Scanning (iscCGM) (2017) (0)
- Diabetes-Technologie (2018) (0)
- The German Fast Track Toward Reimbursement of Digital Health Applications (DiGA): Opportunities and Challenges for Manufacturers, Healthcare Providers, and People With Diabetes. (2022) (0)
- 279-OR: How to Use rtCGM Data to Predict Future Severe Hypoglycemia? (2019) (0)
- Glucose Sensors: Current Status and Further Developments (2000) (0)
- AP@home: An European Project to Bring the Artificial Pancreas Home (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Lutz Heinemann?
Lutz Heinemann is affiliated with the following schools:
